MENU

Articles for ALCHEMIA FPO (ASX: ACL)

Alchemia Limited slammed 53%: Is the stock a buy?

Small-cap biotechnology hopeful Alchemia Limited (ASX:ACL) has experienced a major setback today. More »

5 ASX stocks hammered by the market today

ASX 200 closes flat, but these 5 were sold off by investors More »

Investing lessons from the ASX biotech sector

Alchemia Limited (ASX:ACL) dumped down 83%, while Clinuvel Pharmaceuticals Limited (ASX:CUV) soars 75% More »

4 ASX stocks smashed by the market today

ASX gains 0.8%, but these 4 stocks were slammed More »

3 pharmaceutical stocks with strong prospects

Product pipelines needs to be wide and full for strong and growing earnings. More »